Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03523416 · ClinicalTrials.gov registry record · NA
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
A NA study of Heart Failure, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 15
- Study locations
NCT03523416 is a NA study of Heart Failure that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 71 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 15 study locations across 12 states.
The verdict
NCT03523416, a NA study of Heart Failure, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to evaluate initial clinical safety, device functionality and effectiveness of the Edwards Transcatheter Atrial Shunt System.
Conditions Studied
Interventions
- DEVICE Transcatheter Atrial Shunt System
Study Locations (15)
California
- UC San Diego Health - La Jolla
- University California San Francisco - San Francisco
Minnesota
- Abbott Northwestern - Minneapolis
- Mayo Clinic - Rochester
Ohio
- The Christ Hospital - Cincinnati
- The Ohio State University Medical Center - Columbus
Florida
- University of Florida Health - Jacksonville - Jacksonville
Indiana
- St. Vincent Medical Group - Indianapolis
Kansas
- Kansas University Medical Center - Kansas City
New York
- Montefiore Medical Center - The Bronx
North Carolina
- Atrium Health - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2028-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03523416
The ClinicalTrials.gov registry entry for NCT03523416 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter Atrial Shunt System is the first listed.
NCT03523416 reports 15 study locations spanning 12 distinct geographic areas - top geographies include California, Minnesota, Ohio.
Frequently Asked Questions
What is clinical trial NCT03523416 about?
NCT03523416 is a clinical study titled "Early Feasibility Study - Edwards APTURE Transcatheter Shunt System". The purpose of this study is to evaluate initial clinical safety, device functionality and effectiveness of the Edwards Transcatheter Atrial Shunt System.
What is the current status of trial NCT03523416?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 71 participants. The study started on 2018-07-31. Estimated completion is 2028-11.
What conditions does trial NCT03523416 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03523416?
The interventions under investigation include: Transcatheter Atrial Shunt System (DEVICE).
Who is sponsoring clinical trial NCT03523416?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03523416 being conducted?
This trial has 15 study locations across California, Florida, Indiana, Kansas, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.